Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling.
Day EK, Sosale NG, Xiao A, Zhong Q, Purow B, Lazzara MJ
Cell Rep. 2020 Mar 10;30(10):3383-3396.e7. doi: 10.1016/j.celrep.2020.02.014.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article